Eva Medtec, Inc.

Eva Medtec, Inc. specializes in electric massagers designed for use on beds or chairs. Their primary focus is on products that provide targeted pain relief and muscle recovery, such as the Neuroglide Back Neck Pad, Neuroglide, and the NeoWave Pain Relief and Recovery System (Model# T16-2020). These devices are intended for at-home or clinical use to alleviate discomfort in the back, neck, and other muscle groups.

Eva Medtec, Inc. is based in the United States, which means their devices are subject to FDA regulations. Since they are classified as Class II devices, they must comply with FDA requirements for performance standards, labeling, and post-market surveillance. The U.S. regulatory environment ensures these products meet safety and effectiveness criteria before entering the market.

Eva Medtec, Inc.’s devices are listed in the FDA’s 510(k) and Unique Device Identifier (UDI) registries. The 510(k) process demonstrates that a device is substantially equivalent to a legally marketed predicate device, while the UDI system ensures accurate tracking and identification of medical devices throughout their lifecycle. Listing in these registries helps healthcare providers, regulators, and patients verify the legitimacy and compliance of the products.

Eva Medtec, Inc.’s devices are classified as Class II under FDA regulations, which means they pose moderate risk and require special controls in addition to general controls to ensure safety and effectiveness. This classification typically involves performance standards, post-market surveillance, and labeling requirements. The classification helps determine the regulatory pathway and oversight level for these products.